Free Trial

Alliancebernstein L.P. Sells 43,342 Shares of Azenta, Inc. (NASDAQ:AZTA)

Azenta logo with Medical background

Alliancebernstein L.P. lowered its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 64.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,422 shares of the company's stock after selling 43,342 shares during the period. Alliancebernstein L.P. owned approximately 0.05% of Azenta worth $1,171,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Ballentine Partners LLC grew its position in shares of Azenta by 2.0% during the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock worth $1,017,000 after buying an additional 404 shares during the period. Picton Mahoney Asset Management boosted its stake in Azenta by 305.7% during the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after acquiring an additional 532 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Azenta by 14.9% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company's stock valued at $225,000 after purchasing an additional 576 shares in the last quarter. KBC Group NV boosted its position in shares of Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after purchasing an additional 698 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund boosted its position in shares of Azenta by 7.0% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 10,700 shares of the company's stock worth $535,000 after purchasing an additional 702 shares in the last quarter. 99.08% of the stock is currently owned by institutional investors.

Azenta Price Performance

Shares of AZTA traded up $0.66 during mid-day trading on Thursday, hitting $26.46. The stock had a trading volume of 94,603 shares, compared to its average volume of 662,942. Azenta, Inc. has a 52 week low of $24.06 and a 52 week high of $63.58. The business has a fifty day moving average price of $35.74 and a 200-day moving average price of $43.53. The firm has a market cap of $1.21 billion, a P/E ratio of -8.86 and a beta of 1.66.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. As a group, research analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

AZTA has been the subject of a number of recent research reports. Needham & Company LLC boosted their price target on shares of Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research note on Thursday, February 6th. Stephens reiterated an "overweight" rating and issued a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd. Evercore ISI raised their target price on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research report on Thursday, February 6th. Finally, TD Cowen upgraded shares of Azenta to a "hold" rating in a research report on Thursday, February 27th.

Read Our Latest Stock Analysis on AZTA

About Azenta

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Further Reading

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines